$923.71-0.06 (-0.01%)
The Goldman Sachs Group, Inc., a financial institution, provides a range of financial services for corporations, financial institutions, governments, and individuals in the Americas, Europe, the Middle East, Africa, and Asia.
The Goldman Sachs Group, Inc. in the Financial Services sector is trading at $923.71. The stock is currently near its 52-week high of $984.70, remaining 11.9% above its 200-day moving average. Technical signals show neutral RSI of 60 and bearish MACD signal, explaining why GS maintains its current momentum and trend strength. The Whystock Score of 70/100 reflects a high-conviction bullish alignment.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
The Goldman Sachs Group, Inc., a financial institution, provides a range of financial services for corporations, financial institutions, governments, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. It operates through thre...
IDP Education now sits against an A$4.90 price target, with fair value held at A$6.80. This puts fresh focus on how the gap between trading levels and valuation anchors is being framed. Recent analyst updates around this A$4.90 mark highlight how views are split between concerns over student volume uncertainty and the potential for sentiment to improve if flows stabilise. Read on to see what is driving this evolving narrative and how you can keep track of the key signals from here. Analyst...
Goldman Sachs (NYSE:GS) added UnitedHealth Group (NYSE:UNH) stock to its U.S. Conviction List, reiterating a Buy rating with a $435 price target. The firm argues UnitedHealth is nearing the bottom of its underwriting cycle in Medicare Advantage (MA), which represents 40% of its business. The Conviction List is reserved for Goldman’s highest-conviction Buy ideas. UnitedHealth ... Goldman Sachs Adds UnitedHealth to Its Conviction List: Is the Managed Care Comeback Real?
UnitedHealth Group’s comeback got a serious boost when it scored an earnings beat a couple of weeks ago. Now, it’s being added to Goldman Sachs’ U.S. Conviction List—Director’s Cut, an acclaimed rundown of Buy-rated stocks. Goldman likes the healthcare company’s plans to get smaller in Medicare Advantage, calling it a “shrink to grow” story.
Jane Street's compensation more than doubled as its trading haul outpaced major Wall Street banks and market-making peers.
(Bloomberg) -- OpenAI Chief Financial Officer Sarah Friar pushed back on concerns about missing internal targets, saying the company is meeting objectives and sees “a vertical wall of demand” for its products.Most Read from BloombergTrump Vows 25% Tariff on European Autos in Escalating Trade RiftSpirit Bailout Talks Said to Have Ended With Closure LoomingTrump Family-Backed Drone Firm Signs Weapons Deal With USUS Seeks to Deploy Hypersonic Missile for the First Time Against IranTwo NJ Malls Sepa